Key result
Classical coronary microvascular dysfunction on PET is linked to higher major cardiovascular events vs other phenotypes.
Why the study?
Whether a progressive worsening of coronary function from the epicardial artery to the coronary microcirculation confers worse cardiovascular outcomes in cardio-metabolic disease was investigated.
Does a progressive worsening of PET-determined coronary function from the epicardial artery to the coronary microcirculation confer a higher risk of major adverse cardiovascular events in patients with cardio-metabolic disease?
Cohort (n=329)
No
Does a progressive worsening of PET-determined coronary function from the epicardial artery to the coronary microcirculation confer a higher risk of major adverse cardiovascular events in patients with cardio-metabolic disease?
Answers are grounded in this paper and cite their sources.
In patients with cardiometabolic risk and non-obstructive CAD, 13N-ammonia PET/CT phenotyping demonstrates that a progressive worsening of coronary function from the epicardial artery to classical microvascular dysfunction is associated with a higher univariate incidence of cardiovascular events, although BMI and hsCRP were the only independent predictors on multivariate analysis.
Background To investigate whether a progressive worsening of coronary function from epicardial artery to coronary microcirculation confers worse cardiovascular outcome in cardio-metabolic disease. Methods 13 N-ammonia positron emission tomography (PET) determined rest and pharmacologic-stress myocardial blood flow (MBF) and correspondingt myocardial flow reserve (MFR) in 329 patients. Normal MFR was defined ≥ 2.0, while abnormal MFR of < 2.0 signified coronary microvascular dysfunction (CMD). Subsequently, was then sub-grouped into classical and endogen type. In addition, an abnormal hyperemic longitudinal MBF gradient (MBF-GRAD) ≥ -0.10 mL/g/min, surrogate for impaired epicardial vasodilation, was determined. Patients were assigned into four following groups: group 1, normal MFR and no MBF-GRAD; group 2, normal MFR and MBF-GRAD; group 3 with classical CMD; and group 4 with endogen CMD. Major adverse cardiovascular events (cardiovascular death (CVD), acute coronary syndrome (ACS), myocardial infarction, percutaneous transluminal coronary angioplasty (PCI), coronary artery bypass grafting (CABG), ischemic stroke, or hospitalization due to HFpEF (H-HFpEF)) were assessed. Results During a mean follow-up of 581 ± 288 days, four of group 1 patients H-HFpEF occurred and one patient had a stroke. In group 2, 3, and 4, cardiovascular events occurred in 6 (3 CVD, 1 PCI, and 2 H-HFpEF), 15 (3 CVD, 2 ACS, 5 PCI, 1 CABG, and 5 H-HFpEF), and 2 H-HFpEF, respectively. Patients in group 3 demonstrated a significantly higher incidence of cardiovascular events compared to group 1, 2 and 4, respectively (p < 0.001 log-rank test). Conclusions A progressive worsening of coronary function from epicardial to coronary microcirculation associates with a worse cardiovascular outcome.
No takes yet. Share an insight, caveat, or question.
Mikhail et al. (2026) conducted a cohort in Cardiometabolic disease with suspected coronary microvascular or epicardial dysfunction (n=329). Classical coronary microvascular dysfunction (MFR < 2.0 due to reduced hyperemic MBF) vs. Normal MFR (>= 2.0) with or without abnormal hyperemic longitudinal MBF gradient, and endogen CMD was evaluated on Major adverse cardiovascular events (cardiovascular death, acute coronary syndrome, myocardial infarction, PCI, CABG, ischemic stroke, or hospitalization due to HFpEF) (p=<0.001). Classical coronary microvascular dysfunction on 13N-ammonia PET was associated with a higher incidence of major adverse cardiovascular events compared to other flow phenotypes.
Synapse has enriched 10 related papers. Consider them for comparative context: